Heart Disease Clinical Trials in Seattle

Showing 101-120 of 245 trials

Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial)

NCT04125732

The primary purpose of this trial is to determine the safety of XC001 (AdVEGFXC1) in patients who suffer from angina caused by coronary artery disease and have no other treatment options. Subjects in this study will receive one of four intramyocardial doses of XC001 that expresses human vascular endothelial growth factor (VEGF) which induces therapeutic angiogenesis (revascularization).

Coronary Artery DiseaseIschemiaAngina Refractory+2 more

XyloCor Therapeutics, Inc.41 participantsStarted Jan 2020

Stanford, California, United States • Washington D.C., District of Columbia, United States • Daytona Beach, Florida, United States +13 more locations

UNKNOWNNA< 1 mile

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

NCT03108456

This trial will evaluate Orbital Atherectomy compared to conventional balloon angioplasty technique for the treatment of severely calcified lesions prior to implantation of drug-eluting stents (DES).

Coronary Artery DiseaseIschemic Heart DiseaseNon ST Segment Elevation Myocardial Infarction

Abbott Medical Devices2,005 participantsStarted Mar 2017

Birmingham, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +101 more locations

Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial)

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Heart Disease Trials in Other Cities

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Diagnostic Accuracy of Cardiac CT Perfusion Compared to PET Imaging

Cardiac Cath Lab Staff Radiation Exposure

Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design

Personal Lifestyle Engine (PLX) - Personal Lifestyle Medicine Center (PLMC)

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment

Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial

Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions

Multidisciplinary Approach for High Risk Patients Leading to Early Diagnosis of Canadians in Heart Failure

The Combined Portfolio Diet and Exercise Study

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

Other Conditions in Seattle